Skip to main content

Mycobacterium tuberculosis

Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit

Literatur

  1. 1.

    World Health Organisation (2016) Global tuberculosis report 2016. http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1. Zugegriffen: 25. Juli 2017

    Google Scholar 

  2. 2.

    Fiebig L, Hauer B, Brodhun B, Altmann D, Haas W (2016) Tuberculosis in Germany: a declining trend coming to an end? Eur Respir J 47(2):667–670

    PubMed  Article  Google Scholar 

  3. 3.

    Hauer B, Fiebig L, Brodhun B, Rexroth U, Haas W (2014) Aktuelle Epidemiologie der Tuberkulose weltweit, in Europa und in Deutschland. Pneumologe 11(1):10–20

    Article  Google Scholar 

  4. 4.

    Loddenkemper R, Hauer B (2010) Resistente Tuberkulose: Große Herausforderung durch eine Weltepidemie. Dtsch Arztebl Int 107(1):10–19

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    World Health Organization (2017) Global strategy and targets for tuberculosis prevention, care and control after 2015. Fact sheet 2014. http://www.who.int/tb/post2015_TBstrategy.pdf?ua=1. Zugegriffen: 25. Juli 2017

    Google Scholar 

  6. 6.

    Lönnroth K, Migliori GB, Abubakar I et al (2015) Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 45(4):928–952

    PubMed  PubMed Central  Google Scholar 

  7. 7.

    European Centre for Disease prevention and Control (ECDC) / WHO Regional Office for Europe (2017) Tuberculosis surveillance and monitoring in Europe, 2017. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/ecdc-tuberculosis-surveillance-monitoring-Europe-2017.pdf. Zugegriffen: 25. Juli 2017

    Google Scholar 

  8. 8.

    Houben RMGJ, Dodd PJ (2016) The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med 13(10):1–13

    Article  Google Scholar 

  9. 9.

    Koch R (1882) Die Aetiologie der Tuberculose. Berl Medizinische Wochenschrift 19:221–230

    Google Scholar 

  10. 10.

    Cole ST, Brosch R, Parkhill J et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685):537–544

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Gheorghiu M (1996) Antituberculosis BCG vaccine: lessons from the past. In: Plotkin SA, Fantini B (Hrsg) Vaccinia, Vaccination, Vaccinology. Elsevier, Paris, S 87–96

    Google Scholar 

  12. 12.

    Hesseling AC, Johnson LF, Jaspan H et al (2009) Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants. Bull World Health Org 87(7):505–511

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Lamm DL, van der Meijden PM, Morales A et al (1992) Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 147(3):596–600

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Xie J, Codd C, Mo K, He Y (2016) Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis. PLOS ONE 11(10):e164792. https://doi.org/10.1371/journal.pone.0164792

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  15. 15.

    Gantzer A, Neven B, Picard C et al (2013) Severe cutaneous bacillus Calmette-Guérin infection in immunocompromised children: the relevance of skin biopsy. J Cutan Pathol 40(1):30–37

    PubMed  Article  Google Scholar 

  16. 16.

    Britton WJ, Lockwood DN (2004) Leprosy. Lancet 363(9416):1209–1219

    PubMed  Article  Google Scholar 

  17. 17.

    Stellungnahme des Arbeitskreis Blut (2016) Mycobacterium leprae – Der Erreger von Lepra. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 59:1508–1521

    Article  Google Scholar 

  18. 18.

    Schönfeld N, Haas W, Richter E et al (2013) Empfehlungen zur Diagnostik und Therapie nichttuberkulöser Mykobakteriosen des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). Pneumologie 67:605–633

    PubMed  Article  Google Scholar 

  19. 19.

    Minnikin DE, Lee OYC, Wu HHT et al (2015) Ancient mycobacterial lipids: Key reference biomarkers in charting the evolution of tuberculosis. Tuberculosis, Bd. 95., S 133–S139

    Google Scholar 

  20. 20.

    Arbues A, Lugo-Villarino GC, Neyrolles O, Guilhot C, Astarie-Dequeker C (2014) Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipids. Front Cell Inf 4(173):1–7

    Google Scholar 

  21. 21.

    Ulrichs T, Kaufmann SHE (2003) Immunologie der Tuberkulose. Internist 44(11):1374–1384

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Ulrichs T (2009) Immunologie der Tuberkulose und Impfstoffentwicklung. In: Forßbohm M, Loytved G, Königstein B (Hrsg) Handbuch Tuberkulose für Fachkräfte an Gesundheitsämtern, 1. Aufl. Akademie für öffentliches Gesundheitswesen, Düsseldorf

    Google Scholar 

  23. 23.

    Hauer B, Rohde D, Loddenkemper R (2005) Tuberkulose. Der. Pneumologe 2:291–306

    Article  Google Scholar 

  24. 24.

    Kaufmann SHE (1999) Die Immunantwort gegen Tuberkulose. In: Konietzko N, Loddenkemper R (Hrsg) Tuberkulose. Thieme, Stuttgart, S 62–78

    Google Scholar 

  25. 25.

    Kaufmann SH (2013) Tuberculosis vaccines: time to think about the next generation. Semin Immunol 25(2):172–181

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Pai M, Behr MA, Dowdy D et al (2016) Tuberculosis Disease Primer. Nat Rev 2:1–23

    Google Scholar 

  27. 27.

    Manabe YC, Bishai WR (2000) Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med 6(12):1327–1329

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Corbett EL, Watt CJ, Walker N et al (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163(9):1009–1021

    PubMed  Article  Google Scholar 

  29. 29.

    Lienhardt C, Rodrigues LC (1997) Estimation of the impact of the human immunodeficiency virus infection on tuberculosis: tuberculosis risks re-visited? Int J Tuberc Lung Dis 1(3):196–204

    CAS  PubMed  Google Scholar 

  30. 30.

    Ehlers S (2005) Why does tumor necrosis factor targeted therapy reactivate tuberculosis? J Rheumtol Suppl 74:35–39

    CAS  Google Scholar 

  31. 31.

    Diel R, Hauer B, Loddenkemper R, Manger B, Krüger K (2009) Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren bei rheumatischen Erkrankungen. Pneumologie 63:329–334

    CAS  PubMed  Article  Google Scholar 

  32. 32.

    Marx FM, Dunbar R, Enarson DA et al (2014) The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. Clin Infect Dis 58(12):1676–1683

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Lee ES, Yoon TH, Lee MY, Han SH, Ka JO (2010) Inactivation of environmental mycobacteria by free chlorine and UV. Water Res 44:13299–11334

    Google Scholar 

  34. 34.

    Murdoch LE, Maclean M, Endarko E, MacGregor SJ, Anderson JG (2012) Bactericidal effects of 405 nm light exposure demonstrated by inactivation of Escherichia, Salmonella, Shigella, Listeria, and Mycobacterium species in liquid suspension and on exposed surfaces. Sci World J. https://doi.org/10.1100/2012/137805

    Google Scholar 

  35. 35.

    Fine AE, Bolin CA, Gardiner JC, Kaneene JB (2012) A study of the persistence of Mycobacterium bovis in the environment under natural weather conditions in Michigan, USA. Vet Med Int 26:765430

    Google Scholar 

  36. 36.

    Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces. A systematic review. Bmc Infect Dis 6:130

    PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Ziegler R, Just HM, Castell S et al (2012) Infektionsprävention bei Tuberkulose – Empfehlungen des DZK. Gesundheitswesen 74(6):337–350

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Robert Koch-Institut (2013) Liste der vom Robert Koch-Institut geprüften und anerkannten Desinfektionsmittel und –verfahren. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 56:1706–1728

    Article  Google Scholar 

  39. 39.

    Wells WF (1955) Airborne contagion and air hygiene. An ecological study of droplet infection. Harvard University Press, Cambridge (MA)

    Google Scholar 

  40. 40.

    Rieder HL (1999) Epidemiologic Basis of Tuberculosis Control. International Union Against Tuberculosis and Lung Disease, Paris

    Google Scholar 

  41. 41.

    Diel R, Loytved G, Nienhaus A et al (2011) Neue Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose. Gesundheitswesen 73(6):369–388

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Keijmann J, Tjhie J, Damink OS, Alink M (2001) Unusual nosocomial transmission of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 20:808–809

    Article  Google Scholar 

  43. 43.

    Hutton MD, Stead WW, Cauthen GM, Bloch AB, Ewing WM (1990) Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis 161:286–295

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Comstock GW, Livesay VT, Woolpert SF (1974) The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 99(2):131–138

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Vynnycky E, Fine PE (2000) Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol 152(3):247–263

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Mack U, Migliori GB, Sester M et al (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33(5):956–973

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Horsburgh CR (2004) Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 350:2060–2067

    CAS  PubMed  Article  Google Scholar 

  48. 48.

    Marais BJ, Gie RP, Schaaf HS et al (2004) The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 8(4):392–402

    CAS  PubMed  Google Scholar 

  49. 49.

    Cruz AT, Starke JR (2010) Pediatric tuberculosis. Pediatr Rev 31(1):13–25

    PubMed  Article  Google Scholar 

  50. 50.

    Shaw JB, Wynn-Williams N (1954) Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 69(5):724–732

    CAS  PubMed  Google Scholar 

  51. 51.

    Riley RL (1983) The contagiosity of tuberculosis. Schweiz Med Wochenschr 113:75–79

    CAS  PubMed  Google Scholar 

  52. 52.

    Sepkowitz KA (1996) How contagious is tuberculosis? Clin Infect Dis 23:954–962

    CAS  PubMed  Article  Google Scholar 

  53. 53.

    Behr MA, Warren SA, al Salamon Het (1999) Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353(9151):444–449

    CAS  PubMed  Article  Google Scholar 

  54. 54.

    Tostmann A, Kik SV, Kalisvaart NA et al (2008) Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 47(9):1135–1142

    PubMed  Article  Google Scholar 

  55. 55.

    Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B (2008) Paediatric tuberculosis. Lancet Inf Dis 8(8):498–510

    Article  Google Scholar 

  56. 56.

    Loudon RG, Spohn SK (1969) Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis 99(1):109–111

    CAS  PubMed  Google Scholar 

  57. 57.

    Fennelly KP, Martyny JW, Fulton KE, Orme IM, Cave DM, Heifets LB (2004) Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. Am J Respir Crit Care Med 169(5):604–609

    PubMed  Article  Google Scholar 

  58. 58.

    Loudon RG, Roberts RM (1966) Droplet expulsion from the respiratory tract. Am Rev Respir Dis 95:435–442

    Google Scholar 

  59. 59.

    Dharmadhikari AS, Mphahlele M, Venter K et al (2014) Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 18(9):1019–1025

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  60. 60.

    Rouillon A, Perdrizet S, Parrot R (1976) Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle 57(4):275–299

    CAS  PubMed  Article  Google Scholar 

  61. 61.

    Chapman JS, Dyerly MD (1964) Social and other factors in intrafamilial transmission of tuberculosis. Am Rev Respir Dis 90:48–60

    CAS  PubMed  Google Scholar 

  62. 62.

    Loudon RG, Williamson J, Johnson JM (1958) An analysis of 3,485 tuberculosis contacts in the city of Edinburgh during 1954-1955. Am Rev Tuberc 77(4):623–643

    CAS  PubMed  Google Scholar 

  63. 63.

    Riley RL, Mills CC, O'Grady F, Sultan LU, Wittstadt F, Shivpuri DN (1962) Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. Am Rev Respir Dis 85:511–525

    CAS  PubMed  Google Scholar 

  64. 64.

    Golub JE, Cronin WA, Obasanjo OO et al (2001) Transmission of Mycobacterium tuberculosis through casual contact with an infectious case. Arch Intern Med 161(18):2254–2258

    CAS  PubMed  Article  Google Scholar 

  65. 65.

    Smith S, Jacobs RF, Wilson CB (1997) Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr 131:16–26

    CAS  PubMed  Article  Google Scholar 

  66. 66.

    Guzzetta G, Kirschner D (2013) The roles of immune memory and aging in protective immunity and endogenous reactivation of tuberculosis. PLOS ONE 8(4):e60425

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  67. 67.

    Nhamoyebonde S, Leslie A (2014) Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis 15(Suppl 3):100–106

    Article  Google Scholar 

  68. 68.

    Selwyn PA, Hartel D, Lewis VA et al (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 320:545–550

    CAS  PubMed  Article  Google Scholar 

  69. 69.

    Bucher HC, Griffith LE, Guyatt GH et al (1999) Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS 13:501–507

    CAS  PubMed  Article  Google Scholar 

  70. 70.

    Girardi E, Antonucci G, Vanacore P et al (2000) Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS 14:1985–1991

    CAS  PubMed  Article  Google Scholar 

  71. 71.

    Schaberg T, Bauer T, Castell S et al (2012) Empfehlungen zur Therapie, Chemoprävention und Chemoprophylaxe der Tuberkulose im Erwachsenen- und Kindesalter. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose, Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 66(3):133–171

    CAS  PubMed  Article  Google Scholar 

  72. 72.

    Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5(7):e152

    PubMed  PubMed Central  Article  Google Scholar 

  73. 73.

    Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N (2014) Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology 144(2):171–185

    Article  CAS  Google Scholar 

  74. 74.

    Slama K, Chiang CY, Enarson DA et al (2007) Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 11(10):1049–1061

    CAS  PubMed  Google Scholar 

  75. 75.

    Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR (2007) Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 167(4):335–342

    PubMed  Article  Google Scholar 

  76. 76.

    Story A, Murad S, Roberts W et al (2007) Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax 62(8):667–671

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  77. 77.

    Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M (2009) Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 68(12):2240–2246

    PubMed  Article  Google Scholar 

  78. 78.

    Lacerda SNB, de Abreu Temoteo RC, Monteiro de Figueiredo TMR et al (2014) Individual and social vulnerabilities upon acquiring tuberculosis: a literature systematic review. Int Arch Med 12(7):35

    Article  Google Scholar 

  79. 79.

    van Hest NA, Aldridge RW, de Vries G et al (2014) Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement. Euro Surveill 19(2072):9

    Google Scholar 

  80. 80.

    Robert Koch-Institut (2013) Tuberkulose. RKI-Ratgeber für Ärzte. http://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Tuberkulose.html. Zugegriffen: 25. Juli 2017

    Google Scholar 

  81. 81.

    Haas W, Brodhun B, Starker A (2006) Tuberkulose. Gesundheitsberichterstattung des Bundes, Heft 35. Robert Koch-Institut, Berlin

    Google Scholar 

  82. 82.

    Magdorf K, Bialek R, Detjen AK et al (2013) Tuberkulose und nichttuberkulöse mykobakterielle Krankheiten. In: DGPI Handbuch. Infektionen bei Kindern und Jugendlichen, 6. Aufl. Deutsche Gesellschaft für Pädiatrische Infektiologie e.V. Georg Thieme Verlag KG, Stuttgart, S 551–570

  83. 83.

    Siemon G, Kropp R (1999) Diagnose und Differentialdiagnose der pulmonalen und extrapulmonalen Tuberkulose. In: Konietzko N, Loddenkemper R (Hrsg) Tuberkulose. Thieme, Stuttgart

    Google Scholar 

  84. 84.

    Liebermeister G (1909) Studien über Komplikationen der Lungentuberkulose und über die Verbreitung der Tuberkelbazillen in Organen und im Blut der Phtisiker. Virchows Arch F Path Anat 197:332

    Article  Google Scholar 

  85. 85.

    Faber HK (1914) A culture of bacillus tuberculosis from the blood post mortem of a case of miliary tuberculosis. JAMA 63:1656–1658

    Article  Google Scholar 

  86. 86.

    Clough MC (1917) The cultivation of tubercle bacilli from the circulation blood in miliary tuberculosis. Am Rev Tuberc 1:598–621

    Google Scholar 

  87. 87.

    Ho RS, Fok JS, Harding GE, Smith DW (1978) Host-parasite relationships in experimental airborne tuberculosis. VII. Fate of Mycobacterium tuberculosis in primary lung lesions and in primary lesion-free lung tissue infected as a result of bacillemia. J Infect Dis 138(2):237–241

    CAS  PubMed  Article  Google Scholar 

  88. 88.

    McMurray DN (2003) Hematogenous reseeding of the lung in low-dose, aerosol-infected guinea pigs: unique features of the host-pathogen interface in secondary tubercles. Tuberculosis 83(1):131–134

    PubMed  Article  Google Scholar 

  89. 89.

    Saltzman BR, Motyl MR, Friedland GH, McKitrick JC, Klein RS (1986) Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome. JAMA 256:390–391

    CAS  PubMed  Article  Google Scholar 

  90. 90.

    Barber TW, Craven DE, McCabe WR (1990) Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine (Baltimore) 69(6):375–383

    CAS  Article  Google Scholar 

  91. 91.

    Bouza E, Díaz-López MD, Moreno S, Bernaldo de Quirós JC, Vicente T, Berenguer J (1993) Mycobacterium tuberculosis bacteremia in patients with and without human immunodeficiency virus infection. Arch Intern Med 153(4):496–500

    CAS  PubMed  Article  Google Scholar 

  92. 92.

    Sharafeldin GS, Khalil EA, El Hag IA et al (2007) Haematogenous dissemination of tuberculous lymphadenitis. East Afr Med J 84(1):3–7

    CAS  PubMed  Article  Google Scholar 

  93. 93.

    Schluger NW, Condos R, Lewis S, Rom WN (1994) Amplification of DNA of Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis. Lancet 344(8917):232–233

    CAS  PubMed  Article  Google Scholar 

  94. 94.

    Shafer RW, Goldberg R, Sierra M, Glatt AE (1989) Frequency of Mycobacterium tuberculosis bacteremia in patients with tuberculosis in an area endemic for AIDS. Am Rev Respir Dis 140(6):1611–1613

    CAS  PubMed  Article  Google Scholar 

  95. 95.

    Esteban J, de Gorgolas M, Santos-O'Connor F, Gadea I, Fernández-Roblas R, Soriano F (2001) Mycobacterium tuberculosis bacteremia in a university hospital. Int J Tuberc Lung Dis 5(8):763–768

    CAS  PubMed  Google Scholar 

  96. 96.

    Chiu YS, Wang JT, Chang SC et al (2007) Mycobacterium tuberculosis bacteremia in HIV-negative patients. J Formos Med Assoc 106(5):355–364

    PubMed  Article  Google Scholar 

  97. 97.

    Gopinath K, Kumar S, Singh S (2008) Prevalence of mycobacteremia in Indian HIV-infected patients detected by the MB/BacT automated culture system. Eur J Clin Microbiol Infect Dis 27(6):423–431

    CAS  PubMed  Article  Google Scholar 

  98. 98.

    El Sahly HM, Teeter LD, Musser JM, Graviss EA (2014) Mycobacterium tuberculosis bacteraemia: experience from a non-endemic urban centre. Clin Microbiol Infect 20(3):263–268

    PubMed  Article  Google Scholar 

  99. 99.

    Lewis DK, Peters RP, Schijffelen MJ et al (2002) Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre. Malawi Int J Tuberc Lung Dis 6(12):1067–1074

    CAS  PubMed  Google Scholar 

  100. 100.

    Jacob ST, Pavlinac PB, Nakiyingi L et al (2013) Mycobacterium tuberculosis bacteremia in a cohort of HIV-infected patients hospitalized with severe sepsis in Uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score. PLOS ONE 8(8):e70305

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  101. 101.

    Crump JA, Ramadhani HO, Morrissey AB et al (2012) Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study. Clin Infect Dis 55(2):242–250

    PubMed  PubMed Central  Article  Google Scholar 

  102. 102.

    Ryndak MB, Singh KK, Peng Z et al (2014) Transcriptional profiling of Mycobacterium tuberculosis replicating ex vivo in blood from HIV- and HIV+ subjects. PLOS ONE 9(4):e94939–22

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  103. 103.

    Pavlinac PB, Lokken EM, Walson JL, Richardson BA, Crump JA, John-Stewart GC (2016) Mycobacterium tuberculosis bacteremia in adults and children: a systematic review and meta-analysis. Int J Tuberc Lung Dis 20(7):895–902

    CAS  PubMed  Article  Google Scholar 

  104. 104.

    Nationales Referenzzentrum für Mykobakterien (2014) Präanalytikhandbuch. http://www.fz-borstel.de/cms/fileadmin/content_fz/downloads/Referenzzentrum/NRZ-Praeanalytik.pdf. Zugegriffen: 25. Juli 2017

    Google Scholar 

  105. 105.

    Kropp R, Siemon G (1999) Therapie der Tuberkulose. In: Konietzko N, Loddenkemper R (Hrsg) Tuberkulose. Thieme, Stuttgart, S 137

    Google Scholar 

  106. 106.

    Moon MS, Kim SS, Moon YW, Moon H, Kim SS (2014) Surgery-related complications and sequelae in management of tuberculosis of spine. Asian Spine J 8(4):435–445

    PubMed  PubMed Central  Article  Google Scholar 

  107. 107.

    Chiang SS, Khan FA, Milstein MB et al (2014) Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 14(10):947–957

    PubMed  Article  Google Scholar 

  108. 108.

    Van der Walt M, Lancaster J, Odendaal R, Davis JG, Shean K, Farley J (2013) Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients. PLOS ONE 8(4):e58817

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  109. 109.

    Sturdy A, Goodman A, José RJ et al (2011) Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice. J Antimicrob Chemother 66(8):1815–1820

    CAS  PubMed  Article  Google Scholar 

  110. 110.

    Avong YK, Isaakidis P, Hinderaker SG et al (2015) Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria. PLOS ONE 10(3):e120161

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  111. 111.

    Wilderotter H (1995) Das große Sterben - Seuchen machen Geschichte. Jovis Verlag, Berlin

    Google Scholar 

  112. 112.

    Infektionsschutzgesetz (2000) Bundesgesetzblatt Teil I G5702, S. 1045, Bonn

  113. 113.

    Forßbohm M, Loytved G, Hauer B (2009) Auswirkungen des Infektionsschutzgesetzes auf die Erfassung der Tuberkulose. In: Forßbohm M, Loytved G, Königstein B (Hrsg) Handbuch Tuberkulose für Fachkräfte an Gesundheitsämtern, 1. Aufl. Akademie für öffentliches Gesundheitswesen, Düsseldorf

    Google Scholar 

  114. 114.

    Robert Koch-Institut (2016) Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2016. Robert Koch-Institut, Berlin

    Google Scholar 

  115. 115.

    Dedié K, Bockemühl J, Kühn H, Volkmer K-J, Weinke T (1993) Bakterielle Zoonosen bei Tier und Mensch. Enke Verlag, Stuttgart

    Google Scholar 

  116. 116.

    Humblet M-F, Boschiroli ML, Saegerman C (2009) Classification of worldwide bovine tuberculosis risk factors in cattle: a stratified approach. Vet Res 40:50

    PubMed  PubMed Central  Article  Google Scholar 

  117. 117.

    Snider D (1984) Pregnancy and tuberculosis. Chest 86:10S–13S

    CAS  PubMed  Article  Google Scholar 

  118. 118.

    Whittaker E, Kampmann B (2008) Perinatal tuberculosis. New challenges in the diagnosis and treatment of tuberculosis in infants and the newborn. Early Hum Dev 84:795–799

    PubMed  Article  Google Scholar 

  119. 119.

    Mittal H, Das S, Faridi MM (2014) Management of newborn infant born to mother suffering from tuberculosis: Current recommendations & gaps in knowledge. Indian J Med Res 140(1):32–39

    PubMed  PubMed Central  Google Scholar 

  120. 120.

    Gartner LM, Morton J, Lawrence RA et al (2005) Breastfeeding and the use of human milk. Pediatrics 115(2):496–506

    PubMed  Article  Google Scholar 

  121. 121.

    Subramanian AK (2014) Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Curr Opin Infect Dis 27(4):316–321

    PubMed  Article  Google Scholar 

  122. 122.

    Bumbacea D, Arend SM, Eyuboglu F et al (2012) The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J 40(4):990–1013

    PubMed  Article  Google Scholar 

  123. 123.

    Morris MI, Daly JS, Blumberg E et al (2012) Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report. Am J Transplant 12(9):2288–2300

    CAS  PubMed  Article  Google Scholar 

  124. 124.

    Adamu B, Abdu A, Abba AA, Borodo MM, Tleyjeh IM (2014) Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis (Review). Cochrane Database Syst Rev 4(3):CD8597

    Google Scholar 

  125. 125.

    Ridgeway AL, Warner GS, Phillips P et al (1996) Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor. Am J Respir Critical Care Med 153(3):1166–1168

    CAS  Article  Google Scholar 

  126. 126.

    Winthrop KL, Kubak BM, Pegues DA et al (2004) Transmission of mycobacterium tuberculosis via lung transplantation. Am J Transplant 4(9):1529–1533

    PubMed  Article  Google Scholar 

  127. 127.

    Kiuchi T, Inomata Y, Uemoto S et al (1997) A hepatic graft tuberculosis transmitted from a living-related donor. Transplantation 63(6):905–907

    CAS  PubMed  Article  Google Scholar 

  128. 128.

    Graham JC, Kearns AM, Magee JG et al (2001) Tuberculosis transmitted through transplantation. J Infect 43(4):251–254

    CAS  PubMed  Article  Google Scholar 

  129. 129.

    Weile J, Eickmeyer H, Dreier J et al (2013) First case of Mycobacterium tuberculosis transmission by heart transplantation from donor to recipient. Int J Med Microbiol 303(8):449–451

    PubMed  Article  Google Scholar 

  130. 130.

    Kramer F, Sasse SA, Simms JC, Leedom JM (1993) Primary cutaneous tuberculosis after a needle stick injury from a patient with AIDS and undiagnosed tuberculosis. Ann Intern Med 119:594–595

    CAS  PubMed  Article  Google Scholar 

  131. 131.

    Belchior I, Seabra B, Duarte R (2011) Primary inoculation skin tuberculosis by accidental needle stick. BMJ Case Rep. https://doi.org/10.1136/bcr.11.2010.3496

    PubMed  PubMed Central  Google Scholar 

  132. 132.

    Liu Y, Pan J, Jin K et al (2014) Analysis of 30 patients with acupuncture-induced primary inoculation tuberculosis. PLOS ONE 9(6):e100377

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  133. 133.

    Wang J, Zhu MY, Li C et al (2014) Outbreak of primary inoculation tuberculosis in an acupuncture clinic in southeastern China. Epidemiol Infect 22:1–6

    CAS  Google Scholar 

  134. 134.

    O´Leary PA, Harrison MW (1941) Inoculation tuberculosis. Arch Dermatology Syph 44:371–390

    Article  Google Scholar 

  135. 135.

    Goette DK, Jacobson KW, Doty RD (1978) Primary inoculation tuberculosis of the skin. Protector´s paronychia. Arch Dermatol 114:567–569

    CAS  PubMed  Article  Google Scholar 

  136. 136.

    Diel R, Bauer T, Schaberg T (2013) Tuberkulose Fortschritte in den letzten 10 Jahren und Perspektiven für die weitere Entwicklung. Pneumologe 10:39–46

    Article  Google Scholar 

  137. 137.

    World Health Organization (2011) Collaborative framework for care and control of tuberculosis and diabetes. http://whqlibdoc.who.int/publications/2011/9789241502252_eng.pdf. Zugegriffen: 25. Juli 2017

    Google Scholar 

  138. 138.

    Mo P, Zhu Q, Teter C et al (2014) Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus. Int J Infect Dis 9(28):95–100

    Article  Google Scholar 

  139. 139.

    Merker M, Mona S, Duforet-Frebourg N et al (2015) Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat Genet 47(3):242–249

    CAS  PubMed  Article  Google Scholar 

  140. 140.

    Fiebig L, Kollan C, Hauer B et al (2012) HIV-prevalence in tuberculosis patients in Germany, 2002-2009: an estimation based on HIV and tuberculosis surveillance data. PLOS ONE 7(11):e49111

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  141. 141.

    Moser I, Köhler H, Menge C (2014) Die Tuberkulose des Rindes – überraschend wieder oder immer noch präsent? Tierarztl Prax Ausg G Grosstiere Nutztiere 42(4):240–249

    CAS  PubMed  Google Scholar 

  142. 142.

    Prodinger WM, Eigentler A, Allerberger F et al (2002) Infection of red deer, cattle, and humans with Mycobacterium bovis subsp. caprae in Western Austria. J Clin Microbiol 40:2270–2272

    PubMed  PubMed Central  Article  Google Scholar 

  143. 143.

    Kaneene JB, Miller R, de Kantor IN, Thoen CO (2010) Tuberculosis in wild animals. Int J Tuberc Lung Dis 14:1508–1512

    CAS  PubMed  Google Scholar 

  144. 144.

    Une Y, Mori T (2007) Tuberculosis as a zoonosis from a veterinary perspective. Comp Immun Microbiol Infect Dis 30:415–425

    Article  Google Scholar 

  145. 145.

    Washko RM, Hoefer H, Kiehn TE et al (1998) Mycobacterium tuberculosis infection in a green-winges macaw (Ara chloroptera): report with Public Health implications. J Clin Mirobiol 36:1101–1102

    CAS  Google Scholar 

  146. 146.

    Roberts T, O'Connor C, Nuñez-Garcia J, de la Rua-Domenech R, Smith NH (2014) Unusual cluster of Mycobacterium bovis infection in cats. Vet Rec 174(13):326

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  147. 147.

    Khattak I, Mushtaq MH, Ahmad MU, Khan MS, Haider J (2016) Zoonotic tuberculosis in occupationally exposed groups in Pakistan. Occup Med 66(5):371–376

    CAS  Article  Google Scholar 

  148. 148.

    Gutierrez M, Samper S, Jimenez MS, van Embden JD, Marin JF, Martin C (1997) Identification by spoligotyping of a caprine genotype in Mycobacterium bovis strains causing human tuberculosis. J Clin Microbiol 35:3328–3330

    CAS  PubMed  PubMed Central  Google Scholar 

  149. 149.

    Schmidt V, Schneider S, Schlömer J et al (2008) Transmission of tuberculosis between men and pet birds: a case report. Avian Pathol 37:589–592

    PubMed  Article  Google Scholar 

  150. 150.

    Panteix G, Gutierrez MC, Boschiroli ML et al (2010) Pulmonary tuberculosis due to Mycobacterium microti: a study of six recent cases in France. J Med Microbiol 59:984–989

    CAS  PubMed  Article  Google Scholar 

  151. 151.

    Cousins DV, Bastida R, Cataldi A et al (2003) Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. Nov Int J Syst Evol Microbiol 53:1305–1314

    CAS  PubMed  Article  Google Scholar 

  152. 152.

    Falldefinitionen des Robert Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern. Ausgabe 2015 gemäß § 4 Abs. 2 des Gesetzes zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz – IfSG) http://www.rki.de/DE/Content/Infekt/IfSG/Falldefinition/Downloads/Falldefinitionen_des_RKI.pdf?__blob=publicationFile. Zugegriffen 25. Juli 2017

  153. 153.

    Robert Koch-Institut (2004) Leitfaden zur Übermittlung von Fallberichten zur Tuberkulose. https://www.rki.de/DE/Content/InfAZ/T/Tuberkulose/Download/TB_Leitfaden.pdf?__blob=publicationFile. Zugegriffen: 25. Juli 2017

    Google Scholar 

  154. 154.

    Richter E, Beer J, Diel R et al (2010) MIQ 5: Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. In: Podbielski A, Herrmann M, Kniehl E, Mauch H, Rüssmann H (Hrsg) Heft Tuberkulose / Mykobakteriose, 2010. Aufl. Bd. 2.

    Google Scholar 

  155. 155.

    Boyle D, Pai M (2015) UNITAID Tuberculosis Diagnostics Technology & Market Landscape, 4. Aufl. UNITAID, Vernierhttps://unitaid.eu/assets/Tuberculosis_diagnostics_technology_and_market_landscape_4th_edition_Oct_2015-1.pdf. Zugegriffen: 8. November 2017

  156. 156.

    Hillemann D, Rüsch- Gerdes S, Richter E (2011) Neue molekulardiagnostische Verfahren in der Tuberkulose-Diagnostik. Epi Bull 34:319–321

    Google Scholar 

  157. 157.

    Ling DI, Flores LL, Riley LW, Pai M (2008) Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLOS ONE 3(2):e1536

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  158. 158.

    Mc Hugh TD (2013) Tuberculosis: Diagnosis and Treatment in Advances in molecular and cellular microbiology. CABI, Boston‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬

    Google Scholar 

  159. 159.

    Kohl TA, Niemann S (2015) Gesamtgenomsequenzierung als Mittel zur Aufklärung von Übertragungswegen und Resistenzen von Mycobacterium tuberculosis-Komplex-Stämmen. Epi Bull 11(12):90–91

    Google Scholar 

  160. 160.

    Walker TM, Kohl TA, Omar SV et al (2015) Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Inf Dis 15:1193–1202

    CAS  Article  Google Scholar 

  161. 161.

    Hirtl T (2000) Das Tuberkulin. Von der Geschichte der Tuberkulin-Anwendung über eine Bestandsaufnahme der Gegenwart bis zum Ausblick in eine geforderte Zukunft. Schriftenreihe Gesund in Wien. Literas Universitätsverlag Ges.m.b.H., Wien

    Google Scholar 

  162. 162.

    Sagebiel D, Magdorf K, Loddenkemper R (2005) Von der WHO empfohlenes Tuberkulin PPD RT 23 SSI in Deutschland zugelassen. Pneumologie 59(11):761–762

    CAS  PubMed  Article  Google Scholar 

  163. 163.

    Hauer B, Loddenkemper R, Detjen A et al (2006) Interferon-γ-Tests in der Tuberkulose-Diagnostik - Aktueller Stand. Pneumologie 60:29–44

    CAS  PubMed  Article  Google Scholar 

  164. 164.

    World Health Organization (2011) Commercial serodiagnostic tests for diagnosis of tuberculosis. Policy Statement: 2011. http://apps.who.int/iris/bitstream/10665/70684/1/WHO_HTM_TB_2011.14_eng.pdf?ua=1. Zugegriffen: 25. Juli 2017

    Google Scholar 

  165. 165.

    Hauer B, Diel R, Priwitzer M, Rüsch-Gerdes S, Schaberg T, Loddenkemper R (2008) Der neue Tuberkulose-Schnelltest von Diavita – keine Verbesserung der diagnostischen Möglichkeiten. Pneumologie 62(8):480–481

    CAS  PubMed  Article  Google Scholar 

  166. 166.

    WHO (2016) Treatment guidelines for drug-resistant tuberculosis – 2016 update. http://www.who.int/tb/areas-of-work/drug-resistant-tb/MDRTBguidelines2016.pdf. Zugegriffen: 25. Juli 2017

    Google Scholar 

  167. 167.

    Lange C, Abubakar I, Alffenaar JW et al (2014) Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J 44(1):23–63

    PubMed  PubMed Central  Article  Google Scholar 

  168. 168.

    Arbeitskreis Tuberkulose im Fachausschuss Infektionsschutz des Berufsverbandes der Ärztinnen und Arzte des ÖGD (2012) Sicherung des Behandlungserfolges bei Tuberkulose. Epid Bull 11:93–95

    Google Scholar 

  169. 169.

    Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM (2012) Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 12(2):157-166

  170. 170.

    St IK (1998) Mitteilung der Ständigen Impfkommission am Robert Koch-Institut: Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epid Bull 15:98

    Google Scholar 

  171. 171.

    World Health Organization (2004) BCG vaccine. WHO position paper. Wkly Epidemiol Rec 79(4):27–38

    Google Scholar 

  172. 172.

    Bundesärztekammer (2010) Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). http://www.bundesaerztekammer.de/fileadmin/user_upload/downloads/RiliHaemotherapie2010.pdf. Zugegriffen: 25. Juli 2017

    Google Scholar 

Download references

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mycobacterium tuberculosis. Bundesgesundheitsbl 61, 100–115 (2018). https://doi.org/10.1007/s00103-017-2660-4

Download citation